CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 8-K Event Other events
- 4 Grant or award Director acquired 5,349 shares (grant or award)
- 4 Grant or award Director acquired 6,740 shares (grant or award)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,775 shares (to pay taxes)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4/A Shares withheld for taxes Chief Medical Officer gave up 7,382 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 7,382 shares (to pay taxes)
- 4 Grant or award Director acquired 7,616 shares (grant or award)
- 4 Grant or award Director acquired 9,609 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 28 · 548 filings